Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.
about
Vaccines against malariaAcquired immunity to malariaMolecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donorProfiling the host response to malaria vaccination and malaria challengeVaccines against malariaProlonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasitesMalaria: progress, perils, and prospects for eradicationDiscovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine DevelopmentPlasmodium vivax Controlled Human Malaria Infection - Progress and ProspectsTranscriptional analysis of the pre-erythrocytic stages of the rodent malaria parasite, Plasmodium yoeliiAdenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adultsPlasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trialCharacterization of Plasmodium falciparum sporozoite surface protein 2Control of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements.Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Analysis of the human antibody response to thrombospondin-related anonymous protein of Plasmodium falciparum.Malaria vaccine research and development: the role of the WHO MALVAC committeeExtreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites.Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in miceMinimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoitesAn unstable Th epitope of P. falciparum fosters central memory T cells and anti-CS antibody responses.Identification of pre-erythrocytic malaria antigens that target hepatocytes for killing in vivo and contribute to protection elicited by whole-parasite vaccination.Integrated approach to malaria control.Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India.Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoeliiVectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in miceSusceptibility of different strains of mice to hepatic infection with Plasmodium berghei.Immune responses and protection of Aotus monkeys immunized with irradiated Plasmodium vivax sporozoitesDNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in miceMeasuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults.Inhibition of T cell function during malaria: implications for immunology and vaccinology.Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasitesImpact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection.T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic.A next-generation genetically attenuated Plasmodium falciparum parasite created by triple gene deletion.Superinfection in malaria: Plasmodium shows its iron will.Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02AA novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites.A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate.
P2860
Q17485685-DA1A44F7-2C0E-466E-B3F7-98D0F655B582Q24651173-7FDDD9A6-4FB9-4619-B4CB-9949E36A4536Q24798369-F1ACE750-8602-4257-A60C-EE1CBF75BBBDQ26800494-D4268B71-D4FC-4AFD-A94D-2B2109C9DB55Q26995079-FD0C5FF5-6D76-425D-AF1F-471479EC7FFDQ27314913-BD1AB82C-487A-4382-8060-4A248494E8B2Q27485634-BABB3C18-AA4A-4446-A593-01B531C7C8AEQ27972709-38DDD936-3317-4BB1-8476-0C06CC57ED30Q28066456-FD221F52-0112-4D07-BAAD-052563F3548BQ28473729-4BC2CBD6-56CA-4848-92CE-3E15B7219185Q28744149-DA629C97-E674-4E71-8CE5-7213BC46AF3AQ28748765-1AB158B9-DD60-40FA-9FB2-5FFDDD365F95Q30044857-D786ECA4-B11F-45A7-A33B-943B1687000CQ30565638-E8198FCB-A31B-4A3B-AA52-445E9CDF475AQ33587443-6E46AE88-7971-44C9-A38C-B361E3BD2F4DQ33605857-06710154-BD7D-48D9-9B65-4C9023B1661CQ33611463-A3B395A3-894A-4144-B280-9F92B35CB846Q33640306-32191201-D39C-480C-930F-07A7319DBAABQ33759135-B83F2084-2D46-4F85-BD6C-716F95A4D7C7Q33826130-3D648865-FA61-409E-B166-1A5BAAAF4F69Q33830488-18A2C923-10B4-4A54-8481-E9D7B2797316Q33905005-43CA0C37-6B1F-49A7-B10E-E8DBFA8F2D95Q33906271-09A3D4EC-8461-4C37-AC79-FAEFCAE1D36EQ34002992-9C8545DF-A254-4BF7-9052-9DC9438E2CA7Q34109763-96F7DCEF-FD3D-4B4F-926F-B9D1ADF4B152Q34119885-95C4072E-7AC5-4A28-A32A-4FA5FFABA730Q34543990-B420E5E7-D5C7-49CF-BD2D-92C0EF23C921Q34546225-FF63EC8E-F1A1-49C7-A818-B1A5D9BA77F2Q34606356-E1F49563-8A79-45A7-B68C-E2273391EBECQ34700810-ED47E81B-BAF1-4ED4-8BDE-E93F056BD7BDQ35021277-D0B9AB0C-0485-4BC0-8E0F-EEF938C2272CQ35049876-82F0B131-127B-4562-94AA-2A5FE62C0BD6Q35051549-1AE9813C-8B24-4ADC-8EFE-428EA7A35F45Q35439859-65ABCA9C-4AA2-4A53-9572-37A8F6CFB0AFQ35560038-7F947D78-6217-475F-A095-9AA251B11B98Q35618598-89CB828E-6A76-4DB3-86A8-37A4C015FB63Q35632820-5A6C6AE2-F0FC-4C93-9733-1B463C50BD57Q35689159-1A126CD6-F914-4058-8866-F182FECE5FFEQ35689495-797D7DE1-570A-4767-B36E-D4189A0C1A9AQ35925784-57C97F52-315A-4289-9DBA-24898663DBFD
P2860
Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh-hant
name
Immunization of man against fa ...... use of attenuated sporozoites.
@en
Immunization of man against fa ...... use of attenuated sporozoites.
@nl
type
label
Immunization of man against fa ...... use of attenuated sporozoites.
@en
Immunization of man against fa ...... use of attenuated sporozoites.
@nl
prefLabel
Immunization of man against fa ...... use of attenuated sporozoites.
@en
Immunization of man against fa ...... use of attenuated sporozoites.
@nl
P921
P1476
Immunization of man against fa ...... use of attenuated sporozoites.
@en
P2093
P304
P407
P577
1975-05-01T00:00:00Z